Aarti Surfactants approves Q2 & H1 FY26 results, reconstitutes Risk Management Committee
Aarti Surfactants' Board approved Q2 & H1 FY26 standalone and consolidated financial results. Q2 profit declined QoQ and YoY, while H1 profit grew YoY. The Risk Management Committee was also reconstituted.
The announcement includes the company's financial results, which are key performance indicators for investors and typically have a medium to high impact. The mixed performance (QoQ and YoY quarterly profit decline but YoY half-year growth) moderates the immediate market reaction. The reconstitution of a board committee is a governance update, contributing to a medium overall impact.
The Q2 FY26 financial results show a decline in Net Profit After Tax both quarter-on-quarter and year-on-year for the quarter, despite a year-on-year increase in revenue. However, the half-year (H1 FY26) performance indicates growth in both revenue and net profit compared to H1 FY25, presenting a mixed financial picture. The committee reconstitution is a governance update.
* The Board of Directors of Aarti Surfactants Limited, at its meeting held on November 10, 2025, considered and approved the Unaudited Standalone and Consolidated Financial Results for the Quarter and Half Year ended September 30, 2025. * Standalone Financial Highlights for Q2 FY26 (ended September 30, 2025): * Revenue from Operations (Net): ₹17,916.61 lakhs * Net Profit After Tax: ₹162.88 lakhs * Basic Earnings Per Share (EPS): ₹1.93 * Standalone Financial Highlights for H1 FY26 (ended September 30, 2025): * Revenue from Operations (Net): ₹39,506.53 lakhs * Net Profit After Tax: ₹468.67 lakhs * Basic EPS: ₹5.54 * Consolidated Financial Highlights for Q2 FY26 (ended September 30, 2025): * Revenue from Operations (Net): ₹17,916.61 lakhs * Net Profit After Tax: ₹155.62 lakhs * Basic EPS: ₹1.84 * Consolidated Financial Highlights for H1 FY26 (ended September 30, 2025): * Revenue from Operations (Net): ₹39,506.53 lakhs * Net Profit After Tax: ₹449.99 lakhs * Basic EPS: ₹5.32 * The Board also approved the re-constitution of the Risk Management Committee, with the inclusion of Mr. Parimal H. Desai, a Non-Executive, Non-Independent Director, as a Member, effective November 10, 2025.
What to do with a filing like this
Aarti Surfactants Limited filed this with the NSE as a statutory disclosure, categorised under quarterly results. It is a primary document, not a recommendation, and the desk marks it medium impact: worth reading, rarely worth acting on by itself.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by Aarti Surfactants Limited. Read the original for the full detail.